155 related articles for article (PubMed ID: 21350310)
1. Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients.
Takami T; Terai S; Sakaida I
J Pharmacol Sci; 2011; 115(3):274-8. PubMed ID: 21350310
[TBL] [Abstract][Full Text] [Related]
2. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.
Iwamoto T; Terai S; Hisanaga T; Takami T; Yamamoto N; Watanabe S; Sakaida I
Cell Tissue Res; 2013 Mar; 351(3):487-95. PubMed ID: 23183782
[TBL] [Abstract][Full Text] [Related]
3. Advanced therapies using autologous bone marrow cells for chronic liver disease.
Takami T; Terai S; Sakaida I
Discov Med; 2012 Jul; 14(74):7-12. PubMed ID: 22846198
[TBL] [Abstract][Full Text] [Related]
4. Lesson from the GFP/CCl4 model--translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis.
Terai S; Sakaida I; Nishina H; Okita K
J Hepatobiliary Pancreat Surg; 2005; 12(3):203-7. PubMed ID: 15995808
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow cell infusion therapy for liver cirrhosis.
Sakaida I
J Gastroenterol Hepatol; 2008 Sep; 23(9):1349-53. PubMed ID: 18422964
[TBL] [Abstract][Full Text] [Related]
6. [Autologous bone marrow cell infusion therapy for liver cirrhosis--now and future].
Sakaida I
Rinsho Byori; 2011 Dec; 59(12):1092-8. PubMed ID: 22338911
[TBL] [Abstract][Full Text] [Related]
7. Development of cell therapy using autologous bone marrow cells for liver cirrhosis.
Sakaida I; Terai S; Nishina H; Okita K
Med Mol Morphol; 2005 Dec; 38(4):197-202. PubMed ID: 16378227
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients.
Iwamoto T; Terai S; Mizunaga Y; Yamamoto N; Omori K; Uchida K; Yamasaki T; Fujii Y; Nishina H; Sakaida I
J Gastroenterol; 2012 Mar; 47(3):300-12. PubMed ID: 22065159
[TBL] [Abstract][Full Text] [Related]
9. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
Terai S; Takami T; Yamamoto N; Fujisawa K; Ishikawa T; Urata Y; Tanimoto H; Iwamoto T; Mizunaga Y; Matsuda T; Oono T; Marumoto M; Burganova G; Fernando Quintanilha L; Hidaka I; Marumoto Y; Saeki I; Uchida K; Yamasaki T; Tani K; Taura Y; Fujii Y; Nishina H; Okita K; Sakaida I
Tissue Eng Part B Rev; 2014 Jun; 20(3):206-10. PubMed ID: 24450831
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis.
Maeda M; Takami T; Terai S; Sakaida I
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():104-11. PubMed ID: 22320927
[TBL] [Abstract][Full Text] [Related]
11. Stem cell therapy in chronic liver disease.
Takami T; Terai S; Sakaida I
Curr Opin Gastroenterol; 2012 May; 28(3):203-8. PubMed ID: 22395569
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.
Kim JK; Kim SJ; Kim Y; Chung YE; Park YN; Kim HO; Kim JS; Park MS; Sakaida I; Kim DY; Lee JI; Ahn SH; Lee KS; Han KH
Cell Transplant; 2017 Jun; 26(6):1059-1066. PubMed ID: 28120743
[TBL] [Abstract][Full Text] [Related]
13. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
Tanimoto H; Terai S; Taro T; Murata Y; Fujisawa K; Yamamoto N; Sakaida I
Cell Tissue Res; 2013 Dec; 354(3):717-28. PubMed ID: 24104560
[TBL] [Abstract][Full Text] [Related]
14. Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.
Terai S; Tanimoto H; Maeda M; Zaitsu J; Hisanaga T; Iwamoto T; Fujisawa K; Mizunaga Y; Matsumoto T; Urata Y; Marumoto Y; Hidaka I; Ishikawa T; Yokoyama Y; Aoyama K; Tsuchiya M; Takami T; Omori K; Yamamoto N; Segawa M; Uchida K; Yamasaki T; Okita K; Sakaida I
J Gastroenterol; 2012 May; 47(5):491-7. PubMed ID: 22488349
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow cell infusion therapy for liver cirrhosis patients.
Terai S; Sakaida I
J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):23-5. PubMed ID: 20632039
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor and interleukin-1β are important cytokines in repair of the cirrhotic liver after bone marrow cell infusion: comparison of humans and model mice.
Mizunaga Y; Terai S; Yamamoto N; Uchida K; Yamasaki T; Nishina H; Fujita Y; Shinoda K; Hamamoto Y; Sakaida I
Cell Transplant; 2012; 21(11):2363-75. PubMed ID: 22507241
[TBL] [Abstract][Full Text] [Related]
17. TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion.
Hisanaga T; Terai S; Iwamoto T; Takami T; Yamamoto N; Murata T; Matsuyama T; Nishina H; Sakaida I
Cell Tissue Res; 2011 Oct; 346(1):79-88. PubMed ID: 21987217
[TBL] [Abstract][Full Text] [Related]
18. Canine Liver Fibrosis Model to Assess the Functions of Infused Autologous Bone Marrow-Derived Cells.
Takami T; Tani K; Taura Y; Sakaida I
Methods Mol Biol; 2019; 1905():201-209. PubMed ID: 30536102
[TBL] [Abstract][Full Text] [Related]
19. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.
Terai S; Ishikawa T; Omori K; Aoyama K; Marumoto Y; Urata Y; Yokoyama Y; Uchida K; Yamasaki T; Fujii Y; Okita K; Sakaida I
Stem Cells; 2006 Oct; 24(10):2292-8. PubMed ID: 16778155
[TBL] [Abstract][Full Text] [Related]
20. Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model.
Nishimura T; Takami T; Sasaki R; Aibe Y; Matsuda T; Fujisawa K; Matsumoto T; Yamamoto N; Tani K; Taura Y; Sakaida I
PLoS One; 2019; 14(1):e0210588. PubMed ID: 30673721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
